Literature DB >> 19264476

MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians.

Xian-Hua Gui1, Li-Xin Qiu, Hai-Feng Zhang, De-Ping Zhang, Wen-Zhao Zhong, Jin Li, Yong-Long Xiao.   

Abstract

Published data on the association between MDM2 309 T/G polymorphism and lung cancer risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. A total of eight studies including 6063 cases and 6678 controls were involved in this meta-analysis. Overall, significantly elevated lung cancer risk was associated with GG variant genotype in recessive model when all the eligible studies were pooled into the meta-analysis (OR=1.17; 95% CI=1.02-1.34; P(heterogeneity)=0.06). In the subgroup analysis by ethnicity, significantly increased risks were found among Asians for TG versus TT (OR=1.20; 95% CI=1.05-1.37; P(heterogeneity)=0.30), GG versus TT (OR = 1.34; 95% CI=1.01-1.79; P(heterogeneity)=0.03) and dominant model (OR=1.26; 95% CI=1.11-1.43; P(heterogeneity)=0.14). However, no significant associations were found in both Europeans and Africans for all genetic models. This meta-analysis suggests that the MDM2 309G allele is a low-penetrant risk factor for developing lung cancer in Asians.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264476     DOI: 10.1016/j.ejca.2009.02.002

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck.

Authors:  Hongping Yu; Li-E Wang; Zhensheng Liu; Sheng Wei; Guojun Li; Erich M Sturgis; Qingyi Wei
Journal:  Pharmacogenet Genomics       Date:  2011-07       Impact factor: 2.089

Review 2.  Genetic susceptibility to lung cancer--light at the end of the tunnel?

Authors:  Ariela L Marshall; David C Christiani
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

3.  MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.

Authors:  Yan Wan; Wei Wu; Zhihua Yin; Peng Guan; Baosen Zhou
Journal:  BMC Cancer       Date:  2011-05-29       Impact factor: 4.430

Review 4.  Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review.

Authors:  Lijun Jing; Li Su; Brian Z Ring
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

5.  Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate.

Authors:  Liv B Gansmo; Lars Vatten; Pål Romundstad; Kristian Hveem; Bríd M Ryan; Curtis C Harris; Stian Knappskog; Per E Lønning
Journal:  Oncotarget       Date:  2016-05-10

6.  Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients.

Authors:  C G Stoehr; R Stoehr; A Wenners; A Hartmann; S Bertz; V Spath; B Walter; K Junker; H Moch; R Hinze; S Denzinger; E E Bond; G L Bond; K Bluemke; K Weigelt; V Lieb; E Nolte; P Fornara; B Wullich; H Taubert; S Wach
Journal:  Oncogenesis       Date:  2016-02-29       Impact factor: 7.485

7.  MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.

Authors:  Liv B Gansmo; Merete Bjørnslett; Mari Kyllesø Halle; Helga B Salvesen; Pål Romundstad; Kristian Hveem; Lars Vatten; Anne Dørum; Per E Lønning; Stian Knappskog
Journal:  BMC Cancer       Date:  2017-02-03       Impact factor: 4.430

8.  Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.

Authors:  Wenlei Zhuo; Liang Zhang; Bo Zhu; Junjun Ling; Zhengtang Chen
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

9.  Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.

Authors:  Merete Bjørnslett; Stian Knappskog; Per Eystein Lønning; Anne Dørum
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

10.  MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN.

Authors:  Wenwu He; Jianxiong Long; Lei Xian; Feng Pang; Li Su; Shixiu Wei; Bo Wei; Yanling Hu
Journal:  Exp Ther Med       Date:  2012-07-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.